Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Teresa M. Petrella

Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, T2-041, Toronto, ON, M4N 3M5, Canada

Biography

Teresa Petrella is a Medical Oncologist at the Sunnybrook Odette Cancer Centre in Toronto, Canada and an Associate Professor at the University of Toronto. Dr. Petrella has a BSc in Molecular Biology from the University of Western Ontario and completed her MD from Queen's University.
Publications

Final Efficacy Results of a Randomized Phase II Study of Recombinant Interleukin-21 Compared to Dacarbazine in Patients with Recurrent or Metastatic Melanoma

Objective: Interleukin-21(IL-21) is a T-cell derived cytokine with antitumour activity dependent on NK cells or CD8+ T cells. A previous phase II study demonstrated an overall response rate (ORR) of 22.5% in previously untreated patients with metastatic melanoma. We conducted a multi-centre randomized phase II study in metastatic melanoma patients ... Read More»

Teresa M. Petrella, Catalin Mihalcioiu, Jose Monzon, Elaine McWhirter, Karl Belanger, Kerry J. Savage, Xinni Song, Omid Hamid, Tina Cheng, Mary Davis, Christopher W. Lee, Alan Spatz, Linda Hagerman, Bingshu E. Chen and Janet Dancey

: J Oncol Res Treat 4: 132

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top